Anobis Asset (investor - Others)

Germany
See something wrong or missing? Let us know
Offices:Freiburg
Average round investment:5.51M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: Germany Smartbax
Mostly invests in: Germany Germany (1) Health services (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Anobis Asset

Name Criteria
Germany Peppermint Venture Partners
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Friedrich Georg Hoepfner
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Ireland Jane Gilson
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Bruker
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States AIX Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Cancer Focus Fund
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Gilson Inc.
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Meerkat Holding
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Campus Capital by STS
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Aquarius Invest
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top